Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Results of a Phase II Study of 506U78 (Nelarabine) in Refractory Indolent B-Cell or Peripheral T-Cell Lymphoma.

Michael A. Thompson, MD, PhD, Barbara Pro, MD, Andreas Sarris, MD, PhD, Fredrick B. Hagemeister, MD, Andre Goy, MD, Archie Bleyer, MD, Fernando F. Cabanillas, MD, Felipe Samaniego, MD, MPH, Luis E. Fayad, MD

Blood (2005) 106 (11): 2681.

https://doi.org/10.1182/blood.V106.11.2681.2681

Published: 2005

Journal Articles

Rituximab, Fludarabine, Mitoxantrone, and Dexamethasone (R-FND) for Relapsed Indolent Lymphomas (RIL).

F.B. Hagemeister, MD, P. McLaughlin, MD, L. Fayad, MD, F. Samaniego, MD, N. Dang, MD, A. Goy, MD, J. Romaguera, MD, B. Pro, MD, V. Beasley, R.N., F. Cabanillas, MD, M. Rodriguez, MD

Blood (2005) 106 (11): 941.

https://doi.org/10.1182/blood.V106.11.941.941

Published: 2005

Journal Articles

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

Issa F. Khouri, Rima M. Saliba, Sergio A. Giralt, Ming-Sheng Lee, Grace-Julia Okoroji, Fredrick B. Hagemeister, Martin Korbling, Anas Younes, Cindy Ippoliti, James L. Gajewski, Peter McLaughlin, Paolo Anderlini, Michele L. Donato, Fernando F. Cabanillas, Richard E. Champlin

Blood (2001) 98 (13): 3595–3599.

https://doi.org/10.1182/blood.V98.13.3595

Published: 2001

Journal Articles

ASHAP: A Regimen for Cytoreduction of Refractory or Recurrent Hodgkin’s Disease

J. Rodriguez, M.A. Rodriguez, L. Fayad, P. McLaughlin, F. Swan, A. Sarris, J. Romaguera, B. Andersson, F. Cabanillas, F.B. Hagemeister

Blood (1999) 93 (11): 3632–3636.

https://doi.org/10.1182/blood.V93.11.3632

Published: 1999

Journal Articles

Follicular Large Cell Lymphoma: An Aggressive Lymphoma That Often Presents With Favorable Prognostic Features

J. Rodriguez, P. McLaughlin, F.B. Hagemeister, L. Fayad, M.A. Rodriguez, M. Santiago, M. Hess, J. Romaguera, F. Cabanillas

Blood (1999) 93 (7): 2202–2207.

https://doi.org/10.1182/blood.V93.7.2202

Published: 1999

Journal Articles

Lymphoma classification--the gap between biology and clinical management is closing

W Hiddemann, DL Longo, B Coiffier, RI Fisher, F Cabanillas, F Cavalli, LM Nadler, VT De Vita, TA Lister, JO Armitage

Blood (1996) 88 (11): 4085–4089.

https://doi.org/10.1182/blood.V88.11.4085.4085

Published: 1996

Journal Articles

Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non- Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis

AH Sarris, R Luthra, V Papadimitracopoulou, M Waasdorp, MA Dimopoulos, JA McBride, F Cabanillas, M Duvic, A Deisseroth, SW Morris, WC Pugh

Blood (1996) 88 (5): 1771–1779.

https://doi.org/10.1182/blood.V88.5.1771.1771

Published: 1996

Journal Articles

Alterations in tretinoin pharmacokinetics following administration of liposomal all-trans retinoic acid

E Estey, PF Thall, K Mehta, M Rosenblum, T Jr Brewer, V Simmons, F Cabanillas, R Kurzrock, G Lopez-Berestein

Blood (1996) 87 (9): 3650–3654.

https://doi.org/10.1182/blood.V87.9.3650.bloodjournal8793650

Published: 1996

Journal Articles

A pilot study of high-dose interleukin-3 treatment of relapsed follicular small cleaved-cell lymphoma: hematologic, immunologic, and clinical results [published erratum appears in Blood 1996 Jun 1;87(11):4922]

A Younes, A Sarris, U Consoli, A Rodriguez, P McLaughlin, Y Huh, S Starry, F Cabanillas, M Andreeff

Blood (1996) 87 (5): 1698–1703.

https://doi.org/10.1182/blood.V87.5.1698.1698

Published: 1996

Journal Articles

Identification of B-cell growth factors (interleukin-14; high molecular weight-B-cell growth factors) in effusion fluids from patients with aggressive B-cell lymphomas

R Ford, A Tamayo, B Martin, K Niu, K Claypool, F Cabanillas, J Jr Ambrus

Blood (1995) 86 (1): 283–293.

https://doi.org/10.1182/blood.V86.1.283.bloodjournal861283

Published: 1995

Journal Articles

Decreased expression of the deleted in colorectal carcinoma gene in non- Hodgkin's lymphoma

A Younes, S Zhao, D Jendiroba, HD Kleine, F Cabanillas, M Andreeff

Blood (1995) 85 (10): 2813–2816.

https://doi.org/10.1182/blood.V85.10.2813.bloodjournal85102813

Published: 1995

Journal Articles

Serum levels of interleukin-10 in patients with diffuse large cell lymphoma: lack of correlation with prognosis [see comments]

JE Cortes, M Talpaz, F Cabanillas, JF Seymour, R Kurzrock

Blood (1995) 85 (9): 2516–2520.

https://doi.org/10.1182/blood.V85.9.2516.bloodjournal8592516

Published: 1995

Journal Articles

T-cell-rich B-cell lymphoma

J Rodriguez, WC Pugh, F Cabanillas

Blood (1993) 82 (5): 1586–1589.

https://doi.org/10.1182/blood.V82.5.1586.1586

Published: 1993

Journal Articles

Analysis of the expression of the hybrid gene bcl-2/IgH in follicular lymphomas

P Soubeyran, F Cabanillas, MS Lee

Blood (1993) 81 (1): 122–127.

https://doi.org/10.1182/blood.V81.1.122.122

Published: 1993

Journal Articles

Clinical, biologic, and histologic features of late relapses in diffuse large cell lymphoma

F Cabanillas, WS Velasquez, FB Hagemeister, P McLaughlin, JR Redman

Blood (1992) 79 (4): 1024–1028.

https://doi.org/10.1182/blood.V79.4.1024.1024

Published: 1992

Journal Articles

Establishment and characterization of human B-cell lymphoma cell lines using B-cell growth factor

RJ Ford, A Goodacre, I Ramirez, SR Mehta, F Cabanillas

Blood (1990) 75 (6): 1311–1318.

https://doi.org/10.1182/blood.V75.6.1311.1311

Published: 1990

Journal Articles

Risk classification as the basis for clinical staging of diffuse large- cell lymphoma derived from 10-year survival data

WS Velasquez, S Jagannath, SL Tucker, LM Fuller, LB North, JR Redman, F Swan, FB Hagemeister, P McLaughlin, F Cabanillas

Blood (1989) 74 (2): 551–557.

https://doi.org/10.1182/blood.V74.2.551.551

Published: 1989

Journal Articles

Prognostic factors with high-dose melphalan for refractory multiple myeloma [see comments]

B Barlogie, R Alexanian, L Smallwood, B Cheson, D Dixon, K Dicke, F Cabanillas

Blood (1988) 72 (6): 2015–2019.

https://doi.org/10.1182/blood.V72.6.2015.2015

Published: 1988

Journal Articles

Cytogenetic features of Hodgkin's disease suggest possible origin from a lymphocyte

F Cabanillas, S Pathak, J Trujillo, G Grant, A Cork, FB Hagemeister, WS Velasquez, P McLaughlin, J Redman, R Katz

Blood (1988) 71 (6): 1615–1617.

https://doi.org/10.1182/blood.V71.6.1615.1615

Published: 1988

Journal Articles

Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)

WS Velasquez, F Cabanillas, P Salvador, P McLaughlin, M Fridrik, S Tucker, S Jagannath, FB Hagemeister, JR Redman, F Swan

Blood (1988) 71 (1): 117–122.

https://doi.org/10.1182/blood.V71.1.117.117

Published: 1988

NARROW

Results of a Phase II Study of 506U78 (Nelarabine) in Refractory Indolent B-Cell or Peripheral T-Cell Lymphoma.

Rituximab, Fludarabine, Mitoxantrone, and Dexamethasone (R-FND) for Relapsed Indolent Lymphomas (RIL).

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

ASHAP: A Regimen for Cytoreduction of Refractory or Recurrent Hodgkin’s Disease

Follicular Large Cell Lymphoma: An Aggressive Lymphoma That Often Presents With Favorable Prognostic Features

Lymphoma classification--the gap between biology and clinical management is closing

Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non- Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis

Alterations in tretinoin pharmacokinetics following administration of liposomal all-trans retinoic acid

A pilot study of high-dose interleukin-3 treatment of relapsed follicular small cleaved-cell lymphoma: hematologic, immunologic, and clinical results [published erratum appears in Blood 1996 Jun 1;87(11):4922]

Identification of B-cell growth factors (interleukin-14; high molecular weight-B-cell growth factors) in effusion fluids from patients with aggressive B-cell lymphomas

Decreased expression of the deleted in colorectal carcinoma gene in non- Hodgkin's lymphoma

Serum levels of interleukin-10 in patients with diffuse large cell lymphoma: lack of correlation with prognosis [see comments]

T-cell-rich B-cell lymphoma

Analysis of the expression of the hybrid gene bcl-2/IgH in follicular lymphomas

Clinical, biologic, and histologic features of late relapses in diffuse large cell lymphoma

Establishment and characterization of human B-cell lymphoma cell lines using B-cell growth factor

Risk classification as the basis for clinical staging of diffuse large- cell lymphoma derived from 10-year survival data

Prognostic factors with high-dose melphalan for refractory multiple myeloma [see comments]

Cytogenetic features of Hodgkin's disease suggest possible origin from a lymphocyte

Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only